Open Call for Applications
Non-impedance-based technologies for assessing contact between intracardiac devices and endocardial tissue.
Application Deadline
October 8th, 2026
Award
$50,000
We are seeking innovative, non-impedance-based technologies capable of detecting contact and/or proximity of intracardiac devices, such as electrophysiology (EP) catheters, to the endocardial tissue in a closed heart environment.
The solution should provide a clear indication of contact (required), if possible, proximity, and ideally, force of contact, at a refresh rate of at least 10 times per second.
Approaches based on or dependent on electrical impedance measurement are not within the scope of this call.
Solutions that do not require a change to the EP catheters will be prioritized.
Engineering, physics, materials, chemistry, bioengineering, computational modeling.
Prototype; pre-seed to growth.
Prototypes and strong theoretical foundations.
With relevant prior experience.
Submissions should propose a contact assessment concept that is not impedance-based. Strong proposals will typically include proof-of-concept data, bench testing in a water-tank model, and validation using electrophysiology catheter electrodes at the millimeter scale.
The winner(s) of the challenge shall be eligible for the following:
Cash Award
$50,000
A cash prize of $50,000 will be awarded to the winning company, entrepreneur, or idea.
Investment Option
A path to investment
In addition to the award, the winner will be eligible to pitch that technology for an investment, subject to the approval of the applicable Investment Committee and the satisfactory completion of a due diligence (DD) process.
Applications are reviewed on a rolling basis. Submissions close October 8th, 2026.
Know someone relevant? Please forward this call.
Was this forwarded to you? Join our mailing list.
About Peregrine Ventures
Peregrine Ventures is Israel’s leading healthcare venture capital fund, with a track record spanning biotech, medical devices, and digital health.
Since our founding, we have partnered with entrepreneurs across every stage of growth, from early-stage ideas to companies on the path to M&A and IPO. We work closely with portfolio companies on strategy, regulatory navigation, and building the right partnerships, bringing the experience and network needed to move an innovation from concept to clinical reality.
Subject to terms and conditions of the applicable challenge and execution of an award agreement. Winner selection is at the sole discretion of Peregrine Ventures’ Investment Committee.